May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
A STUDY OF THE ENHANCED CORNEAL PENETRATION OF MOXIFLOXACIN
Author Affiliations & Notes
  • A. Rusinko
    Glaucoma Research,
    Alcon Research Ltd, Fort Worth, TX
  • J. May
    Glaucoma Research,
    Alcon Research Ltd, Fort Worth, TX
  • J. Liao
    Central Sciences,
    Alcon Research Ltd, Fort Worth, TX
  • A. Namil
    Glaucoma Research,
    Alcon Research Ltd, Fort Worth, TX
  • M. Hellberg
    Glaucoma Research,
    Alcon Research Ltd, Fort Worth, TX
  • Footnotes
    Commercial Relationships  A. Rusinko, Alcon Research, Ltd. E; J. May, Alcon Research Ltd E; J. Liao, Alcon Research Ltd E; A. Namil, Alcon Research Ltd E; M. Hellberg, Alcon Research Ltd E.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4907. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Rusinko, J. May, J. Liao, A. Namil, M. Hellberg; A STUDY OF THE ENHANCED CORNEAL PENETRATION OF MOXIFLOXACIN . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4907.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: A high correlation exists between the lipophilicity of a molecule and its corneal penetration rate. The purpose of this study was to identify which molecular properties are responsible for the superior bioavailability of moxifloxacin. Secondly, a mathematical model was developed to predict corneal permeability based upon in vitro data and physiochemical properties of these antibiotics. Methods: Permeabilities of moxifloxacin, ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, lomefloxacin, and gatifloxacin were measured in MDCK (Madin–Darby canine kidney) cells. In vitro corneal penetration rates (cm/s) for five of the fluoroquinolones were reported previously. (Fukada M. and Sasaki, K. In vitro topically applied fluoroquinolone penetration into the anterior chamber. Nippon Ganka Gakkai Sasshi 99:532, 1995). Aqueous solubility, distribution coefficient and pKa were determined experimentally. Results: Moxifloxacin, showed higher lipophilicity, aqueous solubility and MDCK cell permeability than the other fluoroquinolones tested. MDCK cell permeability was highly correlated with both lipophilicity (R2 = 0.92) and corneal permeability (R2 = 0.93). Conclusions: MDCK cell permeability can serve as a predictive model for corneal penetration for fluoroquinolone antibiotics. As a consequence of its higher lipophilicity and greater aqueous solubility, moxifloxacin achieves greater penetration through the cornea and other ocular tissues than any of the other fluoroquinolones tested.

Keywords: antibiotics/antifungals/antiparasitics • anterior segment • computational modeling 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×